Advanced search

Currently, Helen Giza occupies the position of Chief Financial Officer of Fresenius Medical Care AG & Co. KGaA and Chief Financial Officer & Member-Management Board at Fresenius Medical Care Management AG. She is also on the board of Fresenius Medical Care Holdings, Inc. She previously held the position of Area Controller Commercial-Asia Pacific Region at Abbott Laboratories, Vice President & Division Controller at TAP Pharmaceutical Products, Inc., Cost Accountant at ITT, Inc. and Chief Integration & Divestiture Management Officer at Takeda Pharmaceuticals International, Inc. She received an MBA from Kellogg School of Management.

Helen M. Nugent is a businessperson who has been at the helm of 15 different companies. Presently, she holds the position of Chairman of National Portrait Gallery (Australia), Chairman for National Disability Insurance Agency and Chairman for Veda Group Pty Ltd. She is also President of Cranbrook School, Chairman-National Opera Review at Government of Australia and Chancellor at Bond University and on the board of 5 other companies. In the past Dr. Nugent held the position of Chairman at Sydney Airport, Chairman for Australia Council for the Arts, Strategy Director at Westpac Banking Corp., Chairman-Major Performing Arts Inquiry at Australian Major Performing Arts Group, Chairman of Superannuation Funds Management Corp. of South Australia, Non-Executive Chairman of Ausgrid Pty Ltd., Independent Non-Executive Chairman for Equifax Pty Ltd., Chairman of The Mercantile & General Reinsurance Co. of Australia Ltd., Independent Non-Executive Chairman for Equifax Australia Group Pty Ltd., Chairman at Hudson Global Resources (Aust) Pty Ltd., Chairman of Australian Rail Track Corp. Ltd., Chairman at Hudson Global Resources (NZ) Ltd., Chairman of Swiss Re Australia Ltd., Member-Australian Higher Education Review at Australia Department of Education & Training, Partner at Mckinsey & Co., Professor at The University of New South Wales and Professor at Australian Graduate School of Management. Helen M. Nugent received a doctorate and an undergraduate degree from The University of Queensland and an MBA from Harvard University.

Ms. Helen L. Shan is an Independent Director at EPAM Systems, Inc. and a Chief Financial & Revenue Officer at FactSet Research Systems, Inc. She is on the Board of Directors at EPAM Systems, Inc., FactSet Europe Ltd. and Vermilion Holdings Ltd. Ms. Shan was previously employed as a Chief Financial Officer by Mercer Consulting Group, Inc., a Treasurer & Vice President by Marsh & McLennan Cos., Inc., a Treasurer & Vice President by Pitney Bowes, Inc., a Managing Director-Diversified Industries by JPMorgan Securities LLC, and a Controller by Salomon Brothers. She received her undergraduate degree from The Wharton School of the University of Pennsylvania, an undergraduate degree from School of Engineering & Applied Science and an MBA from Johnson Graduate School of Management.

Helen Lofthouse is currently the CEO, Managing Director & Executive Director at ASX Ltd.
She also holds director positions at ASX Clearing Corp.
Ltd., ASX Clear (Futures) Pty Ltd., ASX Clear Pty Ltd., ASX Settlement Corp.
Ltd., ASX Settlement Pty Ltd., and Austraclear Ltd.
Previously, she worked as a Managing Director at UBS Group AG from 2011 to 2015.

Helen I. Torley occupies the position of President, Chief Executive Officer & Director at Halozyme Therapeutics, Inc. She is also on the board of Quest Diagnostics, Inc. and Director & Member-Health Section Governing Board at Biotechnology Innovation Organization and Member of The Royal College of Physicians. In the past she was Vice President & GM-United States Bone Health at Amgen, Inc. and Chief Commercial Officer & Executive VP for Onyx Pharmaceuticals, Inc. (a subsidiary of Amgen, Inc.), Vice President-Medical Affairs of Novartis, Inc., Vice President-Medical Affairs for Sandoz SA and Vice President-Cardiovascular & Metabolic Sales at Bristol-Myers Squibb World Wide Medicines Group. She received an undergraduate degree from the University of Glasgow.

Helen Jane Ashton is the founder of Fire Bright Solutions Ltd., which was founded in 2003.
She is currently an Independent Non-Executive Director at JD Sports Fashion Plc, Director at JLA Total Care Ltd., Director at Direct Catering Products Ltd., Director at Astral Fire & Security Ltd., Director at Atlas Sterile Services Ltd., Director at Atlas Services Holdings Ltd., and Director at T Jolly Facility Services Ltd.
Ms. Ashton's former positions include Chief Executive Officer & Director at Vanilla Group Ltd., Chief Executive Officer at Capquest Group Ltd., Chief Executive Officer at JLA Ltd., Director at JLA EquityCO Ltd.
from 2019 to 2020, Chief Financial Officer at ASOS Plc in 2018, and Chief Operating Officer at Arrow Global Group Ltd.
She obtained an undergraduate degree from The University of Manchester.

Helen Miles is currently the Chief Financial Officer & Executive Director at Severn Trent Plc since 2014.
She is also an Independent Non-Executive Director at Breedon Group Plc since 2021.
Additionally, she holds a position as a Non-Executive Director at the Royal Navy.
Previously, she worked as a Director at Hafren Dyfrdwy Cyfyngedig, Chief Financial Officer at Corente, Inc., and Chief Financial Officer at Openreach Ltd.

Helen McCabe currently works at Rolls-Royce Holdings Plc, as Chief Financial Officer & Director from 2023, Rolls-Royce Group Ltd., as Director from 2023, and Rolls-Royce Plc, as Chief Financial Officer from 2023.

Helen Marie Boudreau is currently an Independent Director at CARA Therapeutics, Inc., Premier, Inc., Shattuck Labs, Inc., Rallybio LLC, Field Trip Health, Inc., Field Trip Psychedelics, Inc., Rallybio Corp., and Managing Director at Estuary Ventures LLC.
Previously, she held positions as Director-Strategic Planning at Yum!.
Brands, Inc., Independent Director at Evaxion Biotech A, Independent Director at Field Trip Health Ltd., Independent Director at Reunion Neuroscience, Inc., Principal at Bank of America Corp., Vice President-Finance, Research & Development at Pfizer Inc., Chief Financial Officer & VP-Investor Relations at Novartis Oncology, Inc., Chief Financial Officer at Novartis Corp., Chief Financial Officer at Forma Therapeutics, Inc., Engagement Manager at McKinsey & Co., Inc., Treasurer, Chief Financial & Accounting Officer at Proteostasis Therapeutics, Inc., and Chief Operating Officer at Bill & Melinda Gates Medical Research Institute.
She obtained an MBA from the University of Virginia Darden School of Business in 1993.

Founder of Next Generation Now, Inc., Helen P. Johnson-Leipold is a businessperson who has been at the head of 8 different companies and presently occupies the position of Chairman & Chief Executive Officer at Johnson Outdoors, Inc., Chairman for Johnson Keland Management, Inc., Chairman of Johnson Financial Group, Inc. and Chairman of Johnson Bank (Wisconsin). She is also on the board of S.C. Johnson & Son, Inc., Commercial Markets Holdco, Inc. and The Prairie School, Inc. and Chairman-Trustees Board at The Johnson Foundation at Wingspread. She previously was Chairman at Diversey, Inc., Chairman at Next Generation Now, Inc., Chairman at Diversey Holdings LLC and Principal at Foote, Cone & Belding Worldwide. She received an undergraduate degree from Cornell University.

Presently, Helen W. Crossen holds the position of Chief Administrative Officer of Annaly Capital Management, Inc. In the past Ms. Crossen held the position of Vice President-Human Resources for NBC Universal, Inc. Ms. Crossen received an undergraduate degree and a graduate degree from Rutgers State University of New Jersey.

Helen Anne Coonan is a businessperson who has been at the head of 9 different companies. She holds the position of Executive Chairman for Crown Resorts Ltd., Chairman of Sydney Harbour Foreshore Authority, Chairman for Supervised Investments Australia Ltd., Chairman of Crown Resorts Foundation Ltd., Chairman at Australian Financial Complaints Authority Ltd. and Co-Chairman of GRACosway. Helen Anne Coonan is also Chairman for Minerals Council of Australia, Member-Corporate Council at European Australian Business Council and Member of Chief Executive Women, Inc. and on the board of 6 other companies. She previously occupied the position of Non-Executive Chairman at HGL Ltd., Partner at Gadens Lawyers (Australia), Minister-Communications at Australian Parliament and Co-Chairman for Government Relations Australia Advisory Ltd. Ms. Coonan received an undergraduate degree and a graduate degree from The University of Sydney.

Siv Helen Rygh Torstensen is Senior VP-Legal & Group General Counsel at Equinor ASA. Ms. Torstensen received a graduate degree from the University of Bergen.

Elena Giza has worked as a Director at Comet SA since 2013.

Helen Young is a member of several professional organizations, including The Chartered Governance Institute, Hong Kong Institute of Certified Public Accountants, The Hong Kong Institute of Chartered Secretaries, and Association of Chartered Certified Accountants (Hong Kong).
She previously worked as a Joint Secretary at Kaisun Holdings Ltd.
from 2010 to 2021.
She holds an MBA from the University of Hong Kong.
Currently, she holds multiple positions, including Member at The Chartered Governance Institute, Hong Kong Institute of Certified Public Accountants, The Hong Kong Institute of Chartered Secretaries, and Association of Chartered Certified Accountants (Hong Kong).

Helen Benz worked as a Chief Financial Officer at American Cleaning Institute.

Helen Guishard is a Member of the Institute of Chartered Accountants in England & Wales and the Institute of Chartered Accountants of Bermuda, where she currently holds positions.
She previously worked as a Financial Controller at American Overseas Group Ltd.
Ms. Guishard obtained an undergraduate degree from the University of Birmingham.

Helen Ellis Grosvenor worked at Mr. Price Group Ltd.
from 2003 to 2017.
She held the position of Secretary from 2012 to 2017.

Helen Zell is currently the Director at Ounce of Prevention Fund.
She previously served as a Trustee at The Museum of Contemporary Art (Illinois).

Helen T.
Kerr is a trustee at The University of Tampa, Inc.

Helen Margaret Page is currently the Director at Virgin Money Giving Ltd.
She also holds the position of Independent Non-Executive Director at The Artisanal Spirits Co. Plc.
In addition, she serves as a Trustee at the Scottish Society for the Prevention of Cruelty to Animals and Scotland's Charity Air Ambulance.
Previously, Ms. Page worked as the Managing Director-Marketing & Innovation at NatWest Group Plc in 2012.
She also held the position of Director-Customer Proposition at Yorkshire Bank Plc.
From 2004 to 2011, she was the Managing Director-Marketing at Direct Line Insurance Ltd.
She then became the Group Director-Innovation & Marketing at Virgin Money UK Plc from 2012 to 2021.
Additionally, she worked as the Managing Director-Marketing & Innovation at The Royal Bank of Scotland Plc.
Prior to that, she was the Head-Brand Marketing at Argos Ltd.
from 2002 to 2004 and the Head-Marketing at The Abbey Group UK Ltd.

Dr. Helen Haworth, CFA, is Managing Director at Credit Suisse Securities (Europe) Ltd.
Dr. Haworth is Head of Global Interest Rate Research and European ABS Research.
She joined Credit Suisse in 2007.
Previously, she was a Senior Credit Analyst in the Fixed Income Team at HSBC Asset Management Canada.
Dr. Haworth holds an MMath in Mathematics from Oxford University and is a CFA charterholder.
She did postdoctoral research in credit modelling at Oxford University, having graduated with a DPhil in Financial Mathematics from Oxford in 2006.

Ms. Helen D.
Stewart is a Principal at Simsum, Inc.

Helen Mix has held the following positions in her career:- Vice President-People at Boardwalk Real Estate Investment Trust since 1999.
-.
Vice President-Human Resources at Boardwalk Real Estate Management Ltd.
since 2004.

Helen Jane Gillies is currently a Non-Executive Director at BAC Holdings Ltd., Monadelphous Group Ltd., Bankstown Airport Pty Ltd., Camden Airport Pty Ltd., and Lexon Insurance Pte Ltd.
She is also a Member of the Australian Institute of Co. Directors.
In the past, she served as an Independent Non-Executive Director at Aurelia Metals Ltd.
and Yancoal Australia Ltd.
She was also a Director & Corporate Counsel at Jacobs Group (Australia) Pty Ltd., Director at Civil Aviation Safety Authority, Director, General Counsel & General Manager-Risk at Sinclair Knight Merz Management Pty Ltd., Non-Executive Director at The Red Flag Group Ltd., and Director at Red Flag Group Holdings Ltd.
Ms. Gillies holds a graduate degree from the University of Melbourne, undergraduate and graduate degrees from The University of Queensland, and an MBA from The University of Sydney.

Helen Lau is currently working as an Analyst at CCB International Securities Ltd.
She previously worked as an Analyst at UOB Kay Hian (Hong Kong) Ltd., Everbright Securities Global (HK) Ltd., and Research Analyst at ZTF Securities Co. Ltd.
From 2015 to 2020, she worked as an Analyst at Argonaut Securities (Asia) Ltd.

Helen Wanjiru Gichohi is an Independent Non-Executive Director at Bamburi Cement Co. Ltd.
and Equity Group Holdings Plc.
She is also a Director at OL Pejeta Conservancy and a Trustee at African Wildlife Foundation, Inc. Previously, she held positions as the Managing Director at Wildlife Conservation Society, Director at Equity Bank (Kenya) Ltd., and Director at Kenya Wildlife Service.
She also served as the Managing Director at Equity Group Foundation from 2012 to 2017 and as the Managing Director at African Conservation Centre.
Dr. Gichohi holds a doctorate degree from the University of Leicester, a graduate degree from the University of Nairobi, and an undergraduate degree from Kenyatta University.

Helen Shik is currently working as Vice President at Schwartz Communications, Inc. since 1996.
She completed her undergraduate degree from Boston University in 1987.

Ms. Helen Wen is an Analyst at ICBC International Research Ltd.
Ms. Wen was previously employed as a Research Analyst by Morgan Stanley Asia Ltd.
and Morgan Stanley Dean Witter Asia Ltd.

Ms. Helen Cameron is Interim Managing Director & Non-Executive Director at CBio Ltd.
She is on the Board of Directors at CBio Ltd.
Ms. Cameron was previously employed as a Research Analyst by Citigroup Global Markets Australia Pty Ltd.

Helen serves as Director of Ventures at Ufi, working with early-stage technology companies focused on the future of work and skills and sits on the board of Learnerbly, Learning Labs and Data Literacy Academy.
Helen has been investing in early-stage ventures since 2002 and early-stage impact ventures since 2016.
Helen was previously Investment Director at Nesta Impact Investments, where she led several investments in high-growth businesses (Applied, Third Space Learning and Oomph) and managed successful exits for the fund (Applied and Reconnections).

Ms. Helen M.
Dickens is President at Fund America Investors Corp.
II and President & Chief Operating Officer at Chotin Asset Management Corp.
Prior to joining Chotin Asset Management Corp.
in June 2005, Ms. Dickens worked at Uniwest Financial Corporation.
Ms. Dickens received her BS in Accounting from the Metropolitan State College of Denver.

Helen Dwyer currently works at Alumni Association of the University of Virginia, as Director-Operations & Business Planning.

Helen Neville is Head of Marketing for SeQuential Biofuels LLC.
Most recently, she was Director of Marketing for Pharmaca Integrative Pharmacy.
Previously, she was a Consultant for IBM and Healthnotes.
Earlier, she worked for HEB Grocery Co. Ms. Neville has 13 years of retail marketing and management experience.
She received a Bachelor's degree in English from the University of Texas in 1992 and an MBA from the University of Colarado in 2001.

Helen Benedict worked as a Marketing Director at PizzaExpress Ltd.